Research by Rutgers Cancer Institute of New Jersey investigators explores the use of a diabetes drug and its impact on pancreatic cancer and finds that targeting a certain signaling pathway with this agent may be a novel strategy for the prevention and treatment of metastatic pancreatic cancer.
Adolescents who smoke e-cigarettes are exposed to significant levels of potentially cancer-causing chemicals also found in tobacco cigarettes, even when the e-cigarettes do not contain nicotine, according to a study by UC San Francisco researchers.
Rutgers Cancer Institute of New Jersey has earned the prestigious accreditation as a provider of continuing nursing education by the American Nurses Credentialing Center (ANCC).
Largest study to date addressing the prevalence of metabolic abnormalities in testicular cancer survivors who received prior chemotherapy publishes findings in the latest issue of JNCCN
Drug therapies that target a specific molecule have changed the way patients are treated for cancer and greatly improved survival rates. However, some patients do not respond to these therapies because the drug is not reaching the tumor cells effectively. In a new study published in Scientific Reports, Moffitt Cancer Center researchers combined single-cell imaging of cancer cells in mice with mathematical modeling to determine which drug characteristics are the most important for efficient drug uptake.
A majority of pediatric cancer providers endorse the use of medical marijuana for children with advanced cancer, according to results of a multicenter survey published in Pediatrics.
Seattle Cancer Care Alliance Medical Director F. Marc Stewart, MD received a silver “Outstanding Medical Director” award from Seattle Business magazine. The award was presented at the magazine’s ninth annual Leaders in Health Care Awards event, held in Seattle at Bell Harbor Convention Center on March 1.
It’s the second-most common cancer killer in the U.S., but misconceptions about colorectal cancer can keep people from accessing the preventive care and treatment they might need. Fred Hutchinson Cancer Research Center experts address some of the most misunderstood aspects of this disease.
Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.
Dr. Petrylak, Professor of Medicine (Medical Oncology) and of Urology; Co-Director, Signal Transduction Research Program, Yale Cancer Center, considers whether PD-L1 biomarkers are useful in the treatment of bladder cancer.
Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States, according to Yale researchers.
The University of Texas MD Anderson Cancer Center and Berkeley Lights, Inc. today announced the launch of Optera Therapeutics Corp, a biopharmaceutical company developing cell therapies with scalable manufacturing solutions for cancer.
Dana-Farber Cancer Institute is establishing a bank of patient-derived xenograft models of more than 750 human tumors.
Roswell Park Comprehensive Cancer Center has been officially approved to administer an FDA-approved CAR T-cell therapy, Yescarta, to lymphoma patients.
Using data from a large ovarian cancer registry, a research team from Roswell Park Comprehensive Cancer Center uncovered a link between testicular cancer and familial ovarian cancer that may be attributable to genetic factors on the X chromosome.
The second location of The Healthy Scratch opened on Roswell Park’s campus. The grab-and-go café provides patients, visitors and employees with a new option for clean eating – and for foods and juices that may help to keep cancer at bay.
A sizable percentage of elderly patients with blood-related cancers such as leukemia and multiple myeloma are apt to show signs of diminished cognitive functioning
Researchers have found strong evidence that environmental exposures, including air pollution, affect gene expressions associated with respiratory diseases much more than genetic ancestry. The study, published today in Nature Communications, analyzed more than 1.6 million data points from biological specimens, health questionnaires and environmental datasets, making this study one of the largest ever to examine the relationship between gene expression and environmental stimuli. These findings represent a groundbreaking use of big data to uncover the environmental factors that are behind diseases and inform strategies for prevention, an approach that would apply to a number of diseases, including cancer.
The annual ‘Ride for the Cure NM’ motorcycle ride raises money and awareness for cancer research and treatment in New Mexico. Every dollar the raised through the ride is donated to The University of New Mexico Comprehensive Cancer Center. Last year, the ride raised more than $3,700.
Women who have one or both breasts removed to treat cancer may have unrealistic expectations about how they’ll feel after that surgery and after breast reconstruction, if they choose that option, a U.S. study suggests. Newsmax Article
23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care will take place March 22 – 24, 2018, in Orlando, Florida, and address value-based healthcare models, payer perspectives, new NCCN Guidelines, and other updates in cancer care.
There’s more to caring for cancer patients than treatments and doctor’s visits. At Rutgers Cancer Institute of New Jersey the Social Work Department is dedicated to treating the ‘whole’ patient by helping them navigate important issues one may not think about in connection with the cancer journey.
With colorectal cancer tabbed as the third leading cause of cancer death among both men and women in the nation, experts from Rutgers Cancer Institute discuss the benefits of screening.
"The same mechanisms that viruses use to cause cancer may be key in combating tumors with immune-based therapies or in keeping cancer from developing in the first place," says Sharon Kuss-Duerkop, PhD.
A powerful resistance mutation that appeared to emerge in melanoma after a patient received a targeted therapy combination, instead was lurking in the tumor all along, primed to thwart treatment before it began, researchers at The University of Texas MD Anderson Cancer Center report online at Cancer Discovery.
Fred Hutchinson Cancer Research Center has announced the 2018 recipients of the annual Harold M. Weintraub Graduate Student Award, which recognizes outstanding achievement in graduate studies in the biological sciences. Nominations for this prestigious award are solicited internationally. This year’s 13 awardees come from the University of Vienna and across the United States.
Scott Weir, Pharm.D., Ph.D., of The University of Kansas Cancer Center, is the recipient of the 2018 Janet Davison Rowley Patient Impact Research Award. Dr. Weir serves as director of the Institute for Advancing Medical Innovation (IAMI) and as associate director for Translational Research at The University of Kansas Cancer Center.
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.
A new, large study led by researchers at Yale Cancer Center shows people with stage III colon cancer who regularly eat nuts are at significantly lower risk of cancer recurrence and mortality than those who don’t.
Bristol-Myers Squibb Company today announced that Yale Cancer Center has joined the International Immuno-Oncology Network (II-ON), a global peer-to-peer collaboration between Bristol-Myers Squibb and academia that aims to advance translational Immuno-Oncology (I-O) science.
A big breakthrough in the battle against breast cancer may have been found in Connecticut.
Yale researchers have developed a set of synthetic molecules that may help boost the strength of a key, virus-fighting protein.
The February Fred Hutch tip sheet includes story ideas ranging from cancer immunotherapy to cloud computing, flu prevention for cancer patients, cystine-dense peptides found in many deadly venoms, gene therapies, serendipitous findings and more.
Innovation and progress in cancer research and care are the result of collaboration and resources. This advancement also extends to cancer prevention and education, but more emphasis on these areas is needed -- especially when it comes to colorectal cancer. So say the directors of both Rutgers Cancer Institute of New Jersey and Rutgers Cancer Institute at University Hospital.
New NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Cancer in People Living With HIV seek to reduce unnecessary, deadly cancer care gaps.
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) announces the selection and implementation of the iEnvision medical affairs platform developed by Envision Technology Solutions.
Michelle Ozbun, PhD, is using two grants totaling $2.7 million to learn how human papillomaviruses (HPV) sneak into cells to reproduce. She and her team are also developing new ways in which to measure infections.
The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives, including more precisely targeting of tumors, and improving upon, and making more available, an existing radiation therapy called adaptive radiation therapy (ART), which is currently only used at highly specialized care centers.
Collaboration aims to accelerate next generation treatments in cancer, gastrointestinal diseases, and neurological disorders
Larotrectinib, a highly selective TRK kinase inhibitor, shows rapid, potent, and durable efficacy in both adult and pediatric patients with solid tumors that harbor TRK fusions, regardless of tumor type or patient age, according to results from three clinical trials published in the New England Journal of Medicine. The landmark data support the foundation of precision oncology by creating a treatment option for a genetically defined cancer while continuing to validate the concept that comprehensive molecular profiling should be strongly considered in people of all ages with advanced solid tumors.
Myers has spent the last decade researching the prevalence, possible causes, management and treatment of chemo-brain.
The University of Texas MD Anderson Cancer Center was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30 percent of the $73.5 million in awards CPRIT announced today. The awards included $16.3 million for individual investigator research including awards for cancer in children and adolescents, computational biology, clinical translation, and prevention and early detection. MD Anderson also received $2 million for recruitment and $4 million for a colorectal cancer prevention coalition award.
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses.
Researchers have shown for the first time that a key protein called KMT2D involved in the epigenetic regulation of gene expression guides this renewal.
UC Davis pathologist Hooman Rashidi is an expert in blood disorders but also a computer programmer. He has married the two disciplines and created must-have learning tools for medical students and residents. His latest is HemeQuiz1, a medical student training app.
New guidelines developed collaboratively by the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network® (NCCN®) offer clinicians much needed recommendations for assessment and management of side effects related to immune checkpoint inhibitors.
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts. This effect, referred to as the “Obesity Paradox”, principally manifested itself in men, said Jennifer McQuade, M.D., lead author and instructor of Melanoma Medical Oncology at The University of Texas MD Anderson Cancer Center.
New oncology leaders for Rutgers Cancer Institute of New Jersey at University Hospital in Newark have been named, further enhancing the facility’s expertise and ability to deliver National Cancer Institute (NCI)-designated Comprehensive Cancer Center services to the greater Essex County region.
A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center report on a phase I clinical trial in the Journal of Clinical Oncology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right